United virus: the oncolytic tag-team against cancer!
- PMID: 20227326
- DOI: 10.1016/j.cytogfr.2010.02.008
United virus: the oncolytic tag-team against cancer!
Abstract
There is an urgent need for innovative therapeutic strategies to treat aggressive metastatic cancers that are incurable with standard therapeutic approaches. Novel treatment strategies like oncolytic virotherapy have led, in some cases, to impressive effects on disease progression in human trials, suggesting that approval of an oncolytic virus therapeutic is on the horizon. While combinations of oncolytic viruses with small molecules are already being tested and have shown promise, we propose that even greater therapeutic synergies could be achieved through rational design of complementary virus therapeutics. In this review, we discuss rational chemical and biological combination strategies to enhance oncolytic virotherapy highlighting the promising combination of vaccinia and vesicular stomatitis oncolytic viruses.
2010 Elsevier Ltd. All rights reserved.
Similar articles
-
[Vesicular stomatitis virus in the fight against cancer].Med Sci (Paris). 2013 Feb;29(2):175-82. doi: 10.1051/medsci/2013292015. Epub 2013 Feb 28. Med Sci (Paris). 2013. PMID: 23452604 Review. French.
-
Virus combinations and chemotherapy for the treatment of human cancers.Curr Opin Mol Ther. 2008 Aug;10(4):371-9. Curr Opin Mol Ther. 2008. PMID: 18683102 Review.
-
Oncolytic vaccinia virus: from bedside to benchtop and back.Curr Opin Mol Ther. 2008 Aug;10(4):387-92. Curr Opin Mol Ther. 2008. PMID: 18683104
-
Novel oncolytic viruses: riding high on the next wave?Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):177-83. doi: 10.1016/j.cytogfr.2010.02.012. Epub 2010 Mar 12. Cytokine Growth Factor Rev. 2010. PMID: 20219409 Review.
-
Oncolytic virotherapy of breast cancer.Gynecol Oncol. 2011 Oct;123(1):164-71. doi: 10.1016/j.ygyno.2011.06.021. Epub 2011 Jul 20. Gynecol Oncol. 2011. PMID: 21764108 Review.
Cited by
-
Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy.Mol Ther. 2014 Jun;22(6):1188-1197. doi: 10.1038/mt.2014.23. Epub 2014 Feb 26. Mol Ther. 2014. PMID: 24569832 Free PMC article.
-
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.Oncolytic Virother. 2018 Mar 28;7:25-35. doi: 10.2147/OV.S137159. eCollection 2017. Oncolytic Virother. 2018. PMID: 29637059 Free PMC article. Review.
-
Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.J Virol. 2013 Feb;87(4):2363-6. doi: 10.1128/JVI.01609-12. Epub 2012 Dec 5. J Virol. 2013. PMID: 23221568 Free PMC article.
-
ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma.Mol Ther Oncolytics. 2015 May 20;2:15008. doi: 10.1038/mto.2015.8. eCollection 2015. Mol Ther Oncolytics. 2015. PMID: 27119105 Free PMC article.
-
The current status of oncolytic viral therapy for head and neck cancer.World J Otorhinolaryngol Head Neck Surg. 2016 Jul 22;2(2):84-89. doi: 10.1016/j.wjorl.2016.05.009. eCollection 2016 Jun. World J Otorhinolaryngol Head Neck Surg. 2016. PMID: 29204552 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
